These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6191422)

  • 1. Prostatic hypertrophy and venereal disease as possible risk factors in the development of bladder cancer.
    Mommsen S; Sell A
    Urol Res; 1983; 11(2):49-52. PubMed ID: 6191422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An epidemiological case-control study of bladder cancer in males from a predominantly rural district.
    Mommsen S; Aagaard J; Sell A
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1205-10. PubMed ID: 6897634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epidemiological study of bladder cancer in a predominantly rural district.
    Mommsen S; Aagaard J; Sell A
    Scand J Urol Nephrol; 1983; 17(3):307-12. PubMed ID: 6689086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of bladder tumor by urine cytology in cases of prostatic hypertrophy.
    Rammou-Kinia R; Anagnostopoulou I
    Diagn Cytopathol; 1996 Dec; 15(5):409-11. PubMed ID: 8989544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marital status, indicators of sexual activity and prostatic cancer.
    La Vecchia C; Franceschi S; Talamini R; Negri E; Boyle P; D'Avanzo B
    J Epidemiol Community Health; 1993 Dec; 47(6):450-3. PubMed ID: 8120498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital and urinary tract diseases and bladder cancer.
    La Vecchia C; Negri E; D'Avanzo B; Savoldelli R; Franceschi S
    Cancer Res; 1991 Jan; 51(2):629-31. PubMed ID: 1985779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey by questionnaire of psychiatric disturbance in patients attending a venereal diseases clinic.
    Pedder JR; Goldberg DP
    Br J Vener Dis; 1970 Feb; 46(1):58-61. PubMed ID: 5467200
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary flow rate in benign prostatic hypertrophy.
    Anikwe RM
    Int Surg; 1976 Feb; 61(2):109-11. PubMed ID: 56317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.
    Fang CW; Liao CH; Wu SC; Muo CH
    World J Urol; 2018 Jun; 36(6):931-938. PubMed ID: 29427001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary neoplasms in bladder diverticula. Review of 5 cases].
    Morote Robles J; de Torres Mateos JA; Palou Redorta J; Cortadellas Angel L
    Arch Esp Urol; 1985; 38(2):159-61. PubMed ID: 3927856
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical characteristics of bladder urothelial tumors in male patients--the influences of benign prostatic hyperplasia/benign prostatic enlargement.
    Zhang NZ; Chen J; Ma L; Xu ZS
    Urol Oncol; 2012 Sep; 30(5):646-51. PubMed ID: 20870428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of non-urological diseases with lower urinary tract symptoms.
    Koskimäki J; Hakama M; Huhtala H; Tammela TL
    Scand J Urol Nephrol; 2001 Oct; 35(5):377-81. PubMed ID: 11771864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital and urinary tract diseases and prostate cancer risk.
    Pelucchi C; Talamini R; Negri E; Franceschi S; La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):254-7. PubMed ID: 16679869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the bladder wall muscle associated with benign prostatic enlargement. A clinical and morphometric study.
    Jakse G; Hoffstädter F
    Urol Res; 1977; 5(3):149-52. PubMed ID: 72445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors for urinary bladder cancer].
    Radosavljevic V; Jankovic S; Markovic-Denic Lj
    Srp Arh Celok Lek; 2001; 129(7-8):180-2. PubMed ID: 11797447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CARCINOMA OF BLADDER TREATED BY SUPERVOLTAGE IRRADIATION.
    LAING AH; DICKINSON KM
    Clin Radiol; 1965 Apr; 16():154-64. PubMed ID: 14272527
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia.
    Homma Y; Yamaguchi T; Kondo Y; Horie S; Takahashi S; Kitamura T
    J Urol; 2002 Jan; 167(1):172-6. PubMed ID: 11743299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a synthetic vasopressin analogue for treatment of nocturia in benign prostatic hypertrophy. A double-blind study.
    Månsson W; Sundin T; Gullberg B
    Scand J Urol Nephrol; 1980; 14(2):139-41. PubMed ID: 6163201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mass screening of prostate in Shiribeshi area in Hokkaido--incidence and clinical symptoms of benign prostatic hypertrophy and prostatic carcinoma].
    Umehara T; Kumamoto Y; Mikuma N; Yamaguchi Y; Tsukamoto T; Miura T; Watanabe H; Ooe H
    Hinyokika Kiyo; 1990 Apr; 36(4):415-23. PubMed ID: 1696062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.